Cas 881833-23-4,1-Piperidinecarboxylic acid, 4-[[[(4-chlorophenyl)methyl]amino]methyl]-, 1,1-dimethylethyl ester

881833-23-4

Post Buying Request

Basic information

Product Name: 1-Piperidinecarboxylic acid, 4-[[[(4-chlorophenyl)methyl]amino]methyl]-, 1,1-dimethylethyl ester
Synonyms:
CAS NO:881833-23-4
Molecular Formula: C18H27ClN2O2
Molecular Weight: 338.878
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-[[[(4-chlorophenyl)methyl]amino]methyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-[[[(4-chlorophenyl)methyl]amino]methyl]-, 1,1-dimethylethyl ester(881833-23-4)
EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-[[[(4-chlorophenyl)methyl]amino]methyl]-, 1,1-dimethylethyl ester(881833-23-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 881833-23-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

881833-23-4 Suppliers

Recommended suppliers

881833-23-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 881833-23-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,1,8,3 and 3 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 881833-23:
(8*8)+(7*8)+(6*1)+(5*8)+(4*3)+(3*3)+(2*2)+(1*3)=194
194 % 10 = 4
So 881833-23-4 is a valid CAS Registry Number.

881833-23-4Upstream product

881833-22-3 tert-butyl 4-(4-chlorobenzylcarbamoyl)piperidine-1-carboxylate

881833-23-4Downstream Products

881833-23-4Relevant academic research and scientific papers

N-sulfonylpiperidine cannabinoid receptor 1 antagonists

-

Page/Page column 12, (2008/06/13)

The present application describes compounds according to Formula I, wherein R1, R2, R3, R4, X and Y are described herein. Additionally, the present application describes pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents. Finally, the present application describes methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 881833-23-4